vs
COMPASS MINERALS INTERNATIONAL INC（CMP）与P3 Health Partners Inc.（PIII）财务数据对比。点击上方公司名可切换其他公司
COMPASS MINERALS INTERNATIONAL INC的季度营收约是P3 Health Partners Inc.的1.0倍（$396.1M vs $384.8M），COMPASS MINERALS INTERNATIONAL INC净利率更高（4.7% vs -19.6%，领先24.3%），COMPASS MINERALS INTERNATIONAL INC同比增速更快（28.9% vs 3.8%），过去两年COMPASS MINERALS INTERNATIONAL INC的营收复合增速更高（4.3% vs -0.5%）
指南针矿产国际是一家美国上市矿产企业，总部位于堪萨斯州欧弗兰帕克，是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐，同时向全球种植者提供植物营养产品，此外也生产民用除冰、水质调节产品及相关商用产品。
P3 Health Partners Inc.是一家总部位于美国的人口健康管理与价值型医疗服务企业，与基层医疗机构及医疗系统合作，为包括联邦医保优势计划参保者在内的人群提供协同优质医疗服务，致力于提升诊疗效果、降低不必要的医疗开支。
CMP vs PIII — 直观对比
营收规模更大
CMP
是对方的1.0倍
$384.8M
营收增速更快
CMP
高出25.1%
3.8%
净利率更高
CMP
高出24.3%
-19.6%
两年增速更快
CMP
近两年复合增速
-0.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $396.1M | $384.8M |
| 净利润 | $18.6M | $-75.5M |
| 毛利率 | 16.0% | — |
| 营业利润率 | 9.2% | -40.0% |
| 净利率 | 4.7% | -19.6% |
| 营收同比 | 28.9% | 3.8% |
| 净利润同比 | 178.8% | -28.8% |
| 每股收益（稀释后） | $0.43 | $-23.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CMPPIII
| Q4 25 | $396.1M | $384.8M | ||
| Q3 25 | $227.5M | $345.3M | ||
| Q2 25 | $214.6M | $355.8M | ||
| Q1 25 | $494.6M | $373.2M | ||
| Q4 24 | $307.2M | $370.7M | ||
| Q3 24 | $208.8M | $362.1M | ||
| Q2 24 | $202.9M | $379.2M | ||
| Q1 24 | $364.0M | $388.5M |
净利润CMPPIII
| Q4 25 | $18.6M | $-75.5M | ||
| Q3 25 | $-7.2M | $-31.6M | ||
| Q2 25 | $-17.0M | $-20.4M | ||
| Q1 25 | $-32.0M | $-20.5M | ||
| Q4 24 | $-23.6M | $-58.6M | ||
| Q3 24 | $-48.3M | $-46.5M | ||
| Q2 24 | $-43.6M | $-12.0M | ||
| Q1 24 | $-38.9M | $-18.7M |
毛利率CMPPIII
| Q4 25 | 16.0% | — | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | 19.2% | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 9.3% | — | ||
| Q2 24 | 16.1% | — | ||
| Q1 24 | 19.7% | — |
营业利润率CMPPIII
| Q4 25 | 9.2% | -40.0% | ||
| Q3 25 | 5.3% | -12.8% | ||
| Q2 25 | 7.4% | -9.6% | ||
| Q1 25 | -0.6% | -10.2% | ||
| Q4 24 | 0.2% | -37.4% | ||
| Q3 24 | -14.3% | -29.5% | ||
| Q2 24 | 2.9% | -8.3% | ||
| Q1 24 | -10.8% | -11.3% |
净利率CMPPIII
| Q4 25 | 4.7% | -19.6% | ||
| Q3 25 | -3.2% | -9.1% | ||
| Q2 25 | -7.9% | -5.7% | ||
| Q1 25 | -6.5% | -5.5% | ||
| Q4 24 | -7.7% | -15.8% | ||
| Q3 24 | -23.1% | -12.8% | ||
| Q2 24 | -21.5% | -3.2% | ||
| Q1 24 | -10.7% | -4.8% |
每股收益（稀释后）CMPPIII
| Q4 25 | $0.43 | $-23.08 | ||
| Q3 25 | — | $-9.67 | ||
| Q2 25 | $-0.41 | $-6.23 | ||
| Q1 25 | $-0.77 | $-6.28 | ||
| Q4 24 | $-0.57 | $-23.13 | ||
| Q3 24 | $-1.17 | $-15.70 | ||
| Q2 24 | $-1.05 | $-7.37 | ||
| Q1 24 | $-0.94 | $-7.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $25.0M |
| 总债务越低越好 | $890.0M | $228.4M |
| 股东权益账面价值 | $260.5M | $-155.2M |
| 总资产 | $1.5B | $656.6M |
| 负债/权益比越低杠杆越低 | 3.42× | — |
8季度趋势，按日历期对齐
现金及短期投资CMPPIII
| Q4 25 | $46.7M | $25.0M | ||
| Q3 25 | $59.7M | $37.7M | ||
| Q2 25 | $79.4M | $38.6M | ||
| Q1 25 | $49.5M | $40.1M | ||
| Q4 24 | $45.8M | $38.8M | ||
| Q3 24 | $20.2M | $63.0M | ||
| Q2 24 | $12.8M | $73.1M | ||
| Q1 24 | $38.3M | $27.3M |
总债务CMPPIII
| Q4 25 | $890.0M | $228.4M | ||
| Q3 25 | $839.8M | $252.8M | ||
| Q2 25 | $833.4M | $182.0M | ||
| Q1 25 | $807.6M | $171.1M | ||
| Q4 24 | $974.4M | $108.9M | ||
| Q3 24 | $921.2M | $133.2M | ||
| Q2 24 | $875.1M | $133.1M | ||
| Q1 24 | $877.2M | $118.1M |
股东权益CMPPIII
| Q4 25 | $260.5M | $-155.2M | ||
| Q3 25 | $234.1M | $-18.7M | ||
| Q2 25 | $249.8M | $44.5M | ||
| Q1 25 | $236.5M | $63.3M | ||
| Q4 24 | $263.0M | $75.9M | ||
| Q3 24 | $316.6M | $120.5M | ||
| Q2 24 | $352.1M | $166.8M | ||
| Q1 24 | $400.4M | $146.6M |
总资产CMPPIII
| Q4 25 | $1.5B | $656.6M | ||
| Q3 25 | $1.5B | $683.6M | ||
| Q2 25 | $1.5B | $731.6M | ||
| Q1 25 | $1.5B | $783.9M | ||
| Q4 24 | $1.7B | $783.4M | ||
| Q3 24 | $1.6B | $833.3M | ||
| Q2 24 | $1.6B | $892.8M | ||
| Q1 24 | $1.7B | $855.9M |
负债/权益比CMPPIII
| Q4 25 | 3.42× | — | ||
| Q3 25 | 3.59× | — | ||
| Q2 25 | 3.34× | 4.09× | ||
| Q1 25 | 3.41× | 2.71× | ||
| Q4 24 | 3.70× | 1.43× | ||
| Q3 24 | 2.91× | 1.11× | ||
| Q2 24 | 2.49× | 0.80× | ||
| Q1 24 | 2.19× | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.0M | $-25.7M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | — |
| 自由现金流率自由现金流/营收 | -15.1% | — |
| 资本支出强度资本支出/营收 | 5.8% | — |
| 现金转化率经营现金流/净利润 | -1.99× | — |
| 过去12个月自由现金流最近4个季度 | $94.1M | — |
8季度趋势，按日历期对齐
经营现金流CMPPIII
| Q4 25 | $-37.0M | $-25.7M | ||
| Q3 25 | $-6.9M | $-15.4M | ||
| Q2 25 | $21.8M | $-16.6M | ||
| Q1 25 | $186.9M | $-33.5M | ||
| Q4 24 | $-4.1M | $-57.2M | ||
| Q3 24 | $-12.7M | $-22.6M | ||
| Q2 24 | $-6.8M | $-10.2M | ||
| Q1 24 | $86.2M | $-20.0M |
自由现金流CMPPIII
| Q4 25 | $-59.8M | — | ||
| Q3 25 | $-22.8M | — | ||
| Q2 25 | $3.8M | — | ||
| Q1 25 | $172.9M | — | ||
| Q4 24 | $-25.9M | — | ||
| Q3 24 | $-33.6M | — | ||
| Q2 24 | $-21.5M | — | ||
| Q1 24 | $56.2M | — |
自由现金流率CMPPIII
| Q4 25 | -15.1% | — | ||
| Q3 25 | -10.0% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 35.0% | — | ||
| Q4 24 | -8.4% | — | ||
| Q3 24 | -16.1% | — | ||
| Q2 24 | -10.6% | — | ||
| Q1 24 | 15.4% | — |
资本支出强度CMPPIII
| Q4 25 | 5.8% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 7.1% | 0.0% | ||
| Q3 24 | 10.0% | 0.0% | ||
| Q2 24 | 7.2% | 0.0% | ||
| Q1 24 | 8.2% | 0.0% |
现金转化率CMPPIII
| Q4 25 | -1.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
